Deanna M. Glassman

Oncology
101 West 8th Avenue
Suite 1400
Spokane, WA 99204

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

A pioneering artificial intelligence tool to predict treatment outcomes in ovarian cancer via diagnostic laparoscopy.

A pioneering artificial intelligence tool to predict treatment outcomes in ovarian cancer via diagnostic laparoscopy.

Journal: Scientific reports
Published: August 28, 2024

TERT promoter mutations and survival outcomes in adult-type granulosa cell tumors.

TERT promoter mutations and survival outcomes in adult-type granulosa cell tumors.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: June 18, 2024

Mechanism and rational combinations with GP-2250, a novel oxathiazine derivative, in ovarian cancer.

Mechanism and rational combinations with GP-2250, a novel oxathiazine derivative, in ovarian cancer.

Journal: Cancer medicine
Published: December 11, 2023

Serial cytoreductive surgery and survival outcomes in recurrent adult-type ovarian granulosa cell tumors.

Serial cytoreductive surgery and survival outcomes in recurrent adult-type ovarian granulosa cell tumors.

Journal: American journal of obstetrics and gynecology
Published: October 09, 2023

Ischemic bowel associated with newly diagnosed patent foramen ovale.

Ischemic bowel associated with newly diagnosed patent foramen ovale.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: September 04, 2023

Posterior-scleritis: Case report of an uncommon immune-related adverse event in the treatment of advanced endometrial cancer.

Posterior-scleritis: Case report of an uncommon immune-related adverse event in the treatment of advanced endometrial cancer.

Journal: Gynecologic oncology reports
Published: July 25, 2023

Endothelial p130cas confers resistance to anti-angiogenesis therapy.

Endothelial p130cas confers resistance to anti-angiogenesis therapy.

Journal: Cell reports
Published: June 05, 2023

Characterizing morphologic subtypes of high-grade serous ovarian cancer by CT: a retrospective cohort study.

Characterizing morphologic subtypes of high-grade serous ovarian cancer by CT: a retrospective cohort study.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: March 22, 2023

Diagnostic and treatment considerations for synchronous cancer of the ovary and endometrium.

Diagnostic and treatment considerations for synchronous cancer of the ovary and endometrium.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: January 05, 2023

Clinical outcomes of leuprolide acetate in the treatment of recurrent ovarian granulosa cell tumors.

Clinical outcomes of leuprolide acetate in the treatment of recurrent ovarian granulosa cell tumors.

Journal: American journal of obstetrics and gynecology
Published: October 31, 2022

Classification of High-Grade Serous Ovarian Cancer Using Tumor Morphologic Characteristics.

Classification of High-Grade Serous Ovarian Cancer Using Tumor Morphologic Characteristics.

Journal: JAMA network open
Published: October 14, 2022

Clinical implications of tumor-based next-generation sequencing in high-grade epithelial ovarian cancer.

Clinical implications of tumor-based next-generation sequencing in high-grade epithelial ovarian cancer.

Journal: Cancer
Published: August 26, 2022
Showing 1-12 of 19

Last Updated: 09/26/2026